PNC Financial Services Group’s CollPlant Biotechnologies CLGN Stock Holding History

PNC Financial Services Group’s Portfolio CLGN Stock Details CLGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-360	Closed	-$17.9K	–	4812
2024 Q2	$17.9K	Hold	360	–	–	﹤0.01%	3533
2024 Q1	$19.3K	Hold	360	–	–	﹤0.01%	3467
2023 Q4	$23K	Hold	360	–	–	﹤0.01%	3355
2023 Q3	$20.1K	Hold	360	–	–	﹤0.01%	3425
2023 Q2	$29.4K	Hold	360	–	–	﹤0.01%	3367
2023 Q1	$25.3K	Hold	360	–	–	﹤0.01%	3383
2022 Q4	$30.1K	Hold	360	–	–	﹤0.01%	3264
2022 Q3	$24K	Hold	360	–	–	﹤0.01%	3363
2022 Q2	$28K	Hold	360	–	–	﹤0.01%	3315
2022 Q1	$40K	Hold	360	–	–	﹤0.01%	3223
2021 Q4	$58K	Buy	+360	New	+$64.2K	﹤0.01%	3019

Other funds holding CLGN

Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

SDJVC

St. Denis J. Villere & Co New Orleans, Louisiana $838M AUM 14.24% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return

BEI

Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

PNC Financial Services Group's CLGN Position: Q3 2024 in Review

PNC Financial Services Group sold out of CollPlant Biotechnologies (CLGN) in Q3 2024, closing a stake of 360 shares — an estimated $17.9K sold.

PNC Financial Services Group first reported a position in CLGN in Q4 2021 and held it in 11 quarters. The position peaked at $58K in Q4 2021. 12 funds tracked by Wall St. Rank hold CLGN as of Q3 2024.

PNC Financial Services Group reported no remaining CollPlant Biotechnologies position as of Q3 2024 after selling out during the quarter.
PNC Financial Services Group sold 360 CollPlant Biotechnologies shares in Q3 2024, an estimated $17.9K.
PNC Financial Services Group first reported a position in CollPlant Biotechnologies in Q4 2021 and held it in 11 quarters.
PNC Financial Services Group's CollPlant Biotechnologies position peaked at $58K in Q4 2021.
12 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q3 2024.

Based on PNC Financial Services Group's 13F filing for Q3 2024, filed 8 Nov 2024.